Lumos Pharma Inc. (NASDAQ: LUMO)
$1.53
-0.0100 ( -0.65% ) 4.0K
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operatesĀ in the United States.
Market Data
Open
$1.53
Previous close
$1.54
Volume
4.0K
Market cap
$12.26M
Day range
$1.51 - $1.56
52 week range
$1.37 - $4.55
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 49 | May 15, 2024 |
10-k/a | Quarterly Reports | 16 | Apr 22, 2024 |
8-k | 8K-related | 16 | Apr 18, 2024 |
ars | Annual reports | 1 | Apr 15, 2024 |
def | Proxies and info statements | 5 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |